Value £268,600,000

Heidi

VC Funding

Series C £100m+

Healthcare & Biotech Published 22 September 2026

Summary

AI healthcare firm Heidi has secured a $340 million investment comprising a $100m Series C round led by Blackbird and a $240m growth investment led by General Catalyst.

Summary of transaction details:

Value: $340 million
Sector: Healthcare & Biotech
Advisor: Not disclosed
Key Entities: Heidi, Blackbird, General Catalyst, Phoenix Court
Location: Melbourne, Australia / United Kingdom

Note: The transaction provides crucial capital to accelerate Heidi's adoption across the NHS and international health systems, enabling the company to scale its workforce and enhance its AI-powered clinical workflow tools.

Lead Investor / Acquirer

Blackbird

Lead Investor / Acquirer

General Catalyst

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Series C prioritised

VC Funding

Scan.com

£67,220,000

Sept 2026

VC Funding

Stream

£67,000,000

Jan 2024

VC Funding

Babylon Health

£24,490,661

May 2020

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

View Company Details

Financials, officers, full deal history

Original Source

View the original press release or news article describing this transaction in full.

Read Original Post

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.